Sphere Fluidics to Present and Exhibit at SynBioBeta 2014 in San Francisco
Dr Marian Rehak (Director of R&D) will be presenting on ESI-Mine (Sphere Fluidics’ new miniaturised, high throughput mass spectrometry platform) at SynBioBeta on 14th of November 2014. “This new platform can screen over 200,000 samples a day, rates of almost 20-fold higher than conventional techniques”, he said. Sphere Fluidics will also be exhibiting at the conference. Dr Frank F. Craig (CEO) said “The Synthetic Biology market is an exciting one, full of innovative and disruptive science. Synthetic biology is a horizontal technology that fits into many vertical markets, such as Pharmaceuticals or Biofuels. Our technology enables high-throughput, low cost analysis of new clones or pathways engineered by synthetic biology means and is thus very valuable”. Conference information can be found here.